Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 5/2013

01-05-2013 | Brief Report

Molecular epidemiology of respiratory syncytial virus during the 2009–2010 season in Latvia

Authors: Reinis Balmaks, Irina Ribakova, Dace Gardovska, Andris Kazaks

Published in: Archives of Virology | Issue 5/2013

Login to get access

Abstract

For the first time, we studied molecular epidemiology of respiratory syncytial virus in hospitalized children in Latvia. During the study period, ten unique group A and three group B strains were identified and assigned to a single genotype within each group—GA2 for group A and BA-IV for group B.
Literature
1.
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EA, Rudan I, Weber MW, Campbell H (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545–1555PubMedCrossRef
2.
Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360:588–598PubMedCrossRef
3.
Mufson MA, Örvell C, Rafnar B, Norrby E (1985) Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 66:2111–2124PubMedCrossRef
4.
Sullender WM (2000) Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev 13:1–15PubMedCrossRef
5.
Nikiforova R, Lucenko I, Zamjatina N (2011) Epidemiology Bulletin No 34. Infectology Center of Latvia, Riga
6.
Wright PF, Cutts FT (2000) Generic protocol to examine the incidence of lower respiratory infection due to respiratory syncytial virus in children less than five years of age: field test version. Department of Vaccines and Biologicals, World Health Organization, Geneva
7.
Martinello RA, Chen MD, Weibel C, Kahn JS (2002) Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis 186:839–842PubMedCrossRef
8.
Balmaks R, Kazaks A, Likopa Z, Grope I, Oskars R, Gardovska D (2011) A new tool for molecular monitoring of respiratory syncytial virus in children with lower respiratory tract infections. Riga Stradins University, Collection of Scientific Papers 2010, pp 100–105
9.
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23:2947–2948PubMedCrossRef
10.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739PubMedCrossRef
11.
Trento A, Galiano M, Garcia-Barreno B, Melero JA, Palomo C (2003) Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol 84:3115–3120PubMedCrossRef
12.
Botosso VF, Zanotto PMdA, Ueda M, Arruda E, Gilio AE, Vieira SE, Stewien KE, Peret TC, Jamal LF, Pardini MI, Pinho JR, Massad E, Sant’anna OA, Holmes EC, Durigon EL, VGDN Consortium (2009) Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog 5:e1000254PubMedCrossRef
13.
Agrawal AS, Sarkar M, Ghosh S, Chawla-Sarkar M, Chakraborty N, Basak M, Naik TN (2009) Prevalence of respiratory syncytial virus group B genotype BA-IV strains among children with acute respiratory tract infection in Kolkata, Eastern India. J Clin Virol 45:358–361PubMedCrossRef
14.
van Niekerk S, Venter M (2011) Replacement of previously circulating respiratory syncytial virus subtype B strains with the BA genotype in South Africa. J Virol 85:8789–8797PubMedCrossRef
15.
Simões EA, Carbonell-Estrany X (2003) Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 22:S13–S18PubMed
16.
Tatochenko V, Uchaikin V, Gorelov A, Gudkov K, Campbell A, Schulz G, Prahl R, Notario G (2010) Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study. Clin Epidemiol 2:221–227PubMed
17.
Galiano MC, Palomo C, Videla CM, Arbiza J, Melero JA, Carballal G (2005) Genetic and antigenic variability of human respiratory syncytial virus (groups A and B) isolated over seven consecutive seasons in Argentina (1995 to 2001). J Clin Microbiol 43:2266–2273PubMedCrossRef
18.
Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M (2007) Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol 45:3022–3030PubMedCrossRef
19.
Reiche J, Schweiger B (2009) Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. J Clin Microbiol 47:1800–1810PubMedCrossRef
20.
Zhang RF, Jin Y, Xie ZP, Liu N, Yan KL, Gao HC, Song JR, Yuan XH, Xiao NG, Guo MW, Zhou QH, Hou YD, Duan Z (2010) Human respiratory syncytial virus in children with acute respiratory tract infections in China. J Clin Microbiol 48:4193–4199PubMedCrossRef
21.
Rafiefard F, Johansson B, Tecle T, Orvell C (2004) Molecular epidemiology of respiratory syncytial virus (RSV) of group A in Stockholm, Sweden, between 1965 and 2003. Virus Res 105:137–145PubMedCrossRef
22.
Yoshida A, Kiyota N, Kobayashi M, Nishimura K, Tsutsui R, Tsukagoshi H, Hirano E, Yamamoto N, Ryo A, Saitoh M, Harada S, Inoue O, Kozawa K, Tanaka R, Noda M, Okabe N, Tashiro M, Mizuta K, Kimura H (2012) Molecular epidemiology of the attachment glycoprotein (G) gene in respiratory syncytial virus in children with acute respiratory infection in Japan in 2009/2010. J Med Microbiol 61:820–829PubMedCrossRef
23.
Zhang ZY, Du LN, Chen X, Zhao Y, Liu EM, Yang XQ, Zhao XD (2010) Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains. J Clin Microbiol 48:1201–1207PubMedCrossRef
24.
Trento A, Casas I, Calderon A, Garcia-Garcia ML, Calvo C, Perez-Brena P, Melero JA (2010) Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol 84:7500–7512PubMedCrossRef
25.
Dapat IC, Shobugawa Y, Sano Y, Saito R, Sasaki A, Suzuki Y, Kumaki A, Zaraket H, Dapat C, Oguma T, Yamaguchi M, Suzuki H (2010) New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan. J Clin Microbiol 48:3423–3427PubMedCrossRef
26.
Peret TCT, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, Tsou C, Anderson LJ (2000) Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis 181:1891–1896PubMedCrossRef
27.
Venter M, Madhi SA, Tiemessen CT, Schoub BD (2001) Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J Gen Virol 82:2117–2124PubMed
28.
Trento A, Viegas M, Galiano M, Videla C, Carballal G, Mistchenko AS, Melero JA (2006) Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication. J Virol 80:975–984PubMedCrossRef
Metadata
Title
Molecular epidemiology of respiratory syncytial virus during the 2009–2010 season in Latvia
Authors
Reinis Balmaks
Irina Ribakova
Dace Gardovska
Andris Kazaks
Publication date
01-05-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 5/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1586-2

Other articles of this Issue 5/2013

Archives of Virology 5/2013 Go to the issue

Original Article

Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice

Original Article

Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160

Brief Review

Hydropericardium syndrome: current state and future developments

Original Article

The secretory pathway and the actomyosin motility system are required for plasmodesmatal localization of the P7-1 of rice black-streaked dwarf virus

Brief Report

New circulating genomic variant of Crimean-Congo hemorrhagic fever virus in Iran

Original Article

Small hepatitis B surface antigen interacts with and modulates enoyl–coenzyme A hydratase expression in hepatoma cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits